Myelodysplastic Syndrome [clinicaltrials_resource:18c8695b242995ae0749765fe68a3446]
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia [clinicaltrials:NCT00001623]Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes [clinicaltrials:NCT00001627]Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults [clinicaltrials:NCT00001637]The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [clinicaltrials:NCT00001873]clinicaltrials:NCT00003838Leucovorin for the Treatment of 5 q Minus Syndrome [clinicaltrials:NCT00004997]clinicaltrials:NCT00005937clinicaltrials:NCT00013533clinicaltrials:NCT00038831Decitabine Versus Supportive Care in Adults With Advanced-stage MDS [clinicaltrials:NCT00043381]Study of Gelonin Purging of Autologous Stem Cells for Transplantation [clinicaltrials:NCT00043810]Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00044382]Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes [clinicaltrials:NCT00045786]Cytogenetic Studies in Acute Leukemia and Multiple Myeloma [clinicaltrials:NCT00048958]Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS) [clinicaltrials:NCT00050154]Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS) [clinicaltrials:NCT00057031]Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML) [clinicaltrials:NCT00064584]clinicaltrials:NCT00067028clinicaltrials:NCT00067808clinicaltrials:NCT00071006clinicaltrials:NCT00088218Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers [clinicaltrials:NCT00089596]clinicaltrials:NCT00110266clinicaltrials:NCT00113321Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [clinicaltrials:NCT00113646]clinicaltrials:NCT00113828A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [clinicaltrials:NCT00136461]Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies [clinicaltrials:NCT00143559]Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation [clinicaltrials:NCT00144703]Stem Cell Transplantation for Patients With Hematologic Malignancies [clinicaltrials:NCT00152139]WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML) [clinicaltrials:NCT00153582]clinicaltrials:NCT00167180Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS [clinicaltrials:NCT00195000]Arsenic Trioxide in Combination With Cytarabine in Patients With High-Risk MDS and Poor-Prognosis AML [clinicaltrials:NCT00195104]To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning [clinicaltrials:NCT00226512]The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00247026]A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00251511]clinicaltrials:NCT00260065Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies [clinicaltrials:NCT00270881]Study of Velcade and Thalidomide in Patients With Myelodysplasia [clinicaltrials:NCT00271804]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Myelodysplastic Syndrome [clinicaltrials_resource:18c8695b242995ae0749765fe68a3446]
Bio2RDF identifier
18c8695b242995ae0749765fe68a3446
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:18c8695b242995ae0749765fe68a3446
identifier
clinicaltrials_resource:18c8695b242995ae0749765fe68a3446
title
Myelodysplastic Syndrome
@en
label
Myelodysplastic Syndrome [clinicaltrials_resource:18c8695b242995ae0749765fe68a3446]
@en